drugset / Trial / NCT03151148

Targeted Microbiome Transplant in Atopic Dermatitis

NCT03151148

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to examine the safety and effectiveness of a new therapy, commensal lotion containing infection fighting bacteria, on decreasing or eliminating the infection causing bacteria found on the skin of Atopic Dermatitis (AD) patients.

Timeline

Start
2017-09-28
Primary completion
2019-05-14
Completion
2019-06-07

Drugs

EvaluationDrugModalityDoseRoute
Subject ShA9 Other / unclassified 2 g Topical

Indications